MedTrace Logo

Effects of Instrument Assisted Soft Tissue Mobilization on Sensory Motor Mismatch in Text Neck Syndrome.

NCT07716137 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2026-07-21

No results posted yet for this study

Summary

Text Neck Syndrome is increasingly common in young adults due to prolonged smartphone use and is linked to postural changes and impaired sensorimotor control. Although its effects on visual-vestibular integration, balance, and proprioception are still unknown, Instrument-Assisted Soft Tissue Mobilization (IASTM) may improve neuromuscular function by enhancing afferent input and mechanoreceptor stimulation. This study investigates whether IASTM can improve sensorimotor processing in individuals with Text Neck Syndrome.

Conditions

  • Text Neck Syndrome

Interventions

OTHER

IASTM + Conventional Physiotherapy

Participants will receive Instrument-Assisted Soft Tissue Mobilization (IASTM) in addition to conventional physiotherapy. IASTM will be applied to the upper trapezius, levator scapulae, sternocleidomastoid, suboccipital muscles, and cervical extensors using stainless steel instruments. Conventional therapy will include cervical isometric exercises, deep cervical flexor activation, scapular strengthening exercises, stretching exercises, thoracic extension exercises, and postural re-education. Treatment will be administered twice weekly for 4 weeks (8 sessions total).

OTHER

Conventional Physiotherapy (Exercise-based) (control group)

Participants will receive conventional physiotherapy consisting of cervical isometric strengthening exercises, deep cervical flexor activation exercises, scapular strengthening exercises, stretching exercises, thoracic extension exercises, and postural re-education. Treatment will be administered twice weekly for 4 weeks (8 sessions total).

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Ramsha Tariq, MS OMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-15
Primary Completion
2026-12-15
Completion
2026-12-25

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07716137 on ClinicalTrials.gov